R
Raphaelle Fanciullino
Researcher at Aix-Marseille University
Publications - 68
Citations - 1233
Raphaelle Fanciullino is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 17, co-authored 63 publications receiving 977 citations. Previous affiliations of Raphaelle Fanciullino include European Organisation for Research and Treatment of Cancer.
Papers
More filters
Journal ArticleDOI
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
Eddy Pasquier,Joseph Ciccolini,Manon Carré,Sarah Giacometti,Raphaelle Fanciullino,Charlotte Pouchy,Marie-Pierre Montero,Cindy Serdjebi,Maria Kavallaris,Nicolas André +9 more
TL;DR: It is suggested that the use of propranolol concurrently with chemotherapy may improve the outcome of breast cancer patients, thus providing a strong rationale for the evaluation of this drug combination in prospective clinical studies.
Journal ArticleDOI
Liposome-encapsulated anticancer drugs: still waiting for the magic bullet?
TL;DR: The achievements, limits, and new expectancies of anticancer drugs as candidates for liposome-encapsulated drugs such as anthracyclines are reviewed.
Journal ArticleDOI
Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs
TL;DR: This review covers the achievements and current limits of nanoparticles in oncology, with a special focus on nab-paclitaxel as a paradigmatic drug for this new generation of conjugated entities.
Journal ArticleDOI
Optimization of trans-Resveratrol bioavailability for human therapy
Marie-Josèphe Amiot,Béatrice Romier,Thi-Mai Anh Dao,Raphaelle Fanciullino,Joseph Ciccolini,Rémy Burcelin,Laurent Pechere,Claude Emond,Jean-François Savouret,Eric Seree,Eric Seree +10 more
TL;DR: The data suggest that significant improvements in t- Res bioavailability and efficiency can be obtained by this soluble galenic form, also allowing lower doses, and the use of t-Res in human therapy is greatly facilitated and the toxicity risk is reduced.
Journal ArticleDOI
Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept
TL;DR: This review covers the physicochemistry ofliposomes and the recent technical improvements in the preparation of liposome-encapsulated drugs in regard to the scientific and medical stakes.